Senseonics Holdings, Inc. (SENS)
NYSEAMERICAN: SENS · Real-Time Price · USD
0.4941
-0.0059 (-1.18%)
Jun 27, 2025, 4:00 PM - Market closed
Senseonics Holdings Revenue
Senseonics Holdings had revenue of $6.26M in the quarter ending March 31, 2025, with 23.97% growth. This brings the company's revenue in the last twelve months to $23.68M, up 1.64% year-over-year. In the year 2024, Senseonics Holdings had annual revenue of $22.47M with 0.37% growth.
Revenue (ttm)
$23.68M
Revenue Growth
+1.64%
P/S Ratio
14.00
Revenue / Employee
$202,410
Employees
117
Market Cap
399.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22.47M | 82.00K | 0.37% |
| Dec 31, 2023 | 22.39M | 6.00M | 36.62% |
| Dec 31, 2022 | 16.39M | 2.71M | 19.85% |
| Dec 31, 2021 | 13.68M | 8.73M | 176.32% |
| Dec 31, 2020 | 4.95M | -16.35M | -76.77% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
SENS News
- 23 days ago - Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes - GlobeNewsWire
- 5 weeks ago - Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement - GlobeNewsWire
- 5 weeks ago - Revisiting Senseonics After 4 Years: Still A Big Investment Opportunity - Seeking Alpha
- 6 weeks ago - Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement - GlobeNewsWire
- 6 weeks ago - Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement - GlobeNewsWire
- 7 weeks ago - Senseonics Holdings, Inc. (SENS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time - GlobeNewsWire
- 2 months ago - Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM) - GlobeNewsWire